IL2 and infection: These data together suggest that IL-10 may be a promising cytokine to target for treatment of infections and inflammatory diseases (50) via decreasing IL-2 secretion by T cells, suppressing activated macrophages and dendritic cells (DC), diminishing the production of cytokines required for effective T helper responses, and reduction of HLA class II expression (40, 50).